Although phase III study of BKM120 in human epidermal growth factor receptor 2 (HER2)‐negative metastatic breast cancer is ongoing, there are currently only phase I trials for BKM120 in advanced CRC 17. The gene discussed is ERBB2; the disease is colorectal carcinoma.